background
sever
acut
respiratori
syndrom
sar
coronaviruslik
virus
continu
circul
anim
reservoir
new
mutant
sar
coronaviru
initi
anoth
epidem
administr
prophylact
antibodi
risk
group
may
supplement
stringent
isol
procedur
contain
first
sar
outbreak
method
develop
mathemat
model
investig
effect
hospit
admiss
target
antibodi
prophylaxi
reproduct
number
r
defin
number
secondari
case
gener
index
case
differ
sar
outbreak
scenario
result
assum
basic
reproduct
number
r
admiss
patient
hospit
within
day
symptom
onset
necessari
achiev
outbreak
control
without
need
reduc
communitybas
transmiss
control
may
enhanc
provid
preexposur
prophylaxi
contact
hospit
patient
contact
trace
provis
postexposur
prophylaxi
antibodi
prophylaxi
may
also
employ
reduc
r
one
therebi
restrict
outbreak
size
durat
conclus
patient
isol
alon
suffici
control
sar
outbreak
provid
time
onset
admiss
short
antibodi
prophylaxi
supplement
measur
gener
allow
contain
higher
r
valu
restrict
size
durat
outbreak
sever
acut
respiratori
syndrom
sar
first
major
outbreak
newli
emerg
communic
diseas
centuri
affect
person
multipl
contin
appear
stir
unpreced
coordin
effort
control
transmiss
morbid
motiv
fear
local
outbreak
might
give
rise
major
pandem
within
month
onset
mathemat
model
proven
use
tool
evalu
impact
control
measur
instig
sar
outbreak
origin
guangdong
provinc
china
spread
hong
kong
next
vietnam
singapor
canada
march
world
health
organ
issu
second
global
alert
togeth
name
new
diseas
case
definit
outbreak
fulli
contain
juli
last
case
occur
canada
sar
coronaviru
caus
agent
new
diseas
like
transmit
human
mask
palm
civet
paguma
larvata
adapt
human
transmiss
possibl
singl
mutat
spike
glycoprotein
civet
sarslik
viru
sarslik
virus
continu
circul
anim
reservoir
risk
anoth
major
outbreak
remain
identif
measur
make
sar
control
key
plan
public
health
respons
futur
outbreak
measur
success
control
sar
epidem
could
probabl
supplement
specif
antivir
strategi
protect
ring
vaccin
target
antibodi
prophylaxi
although
protect
vaccin
sar
still
elus
antibodi
neutral
capac
character
specif
human
monoclon
antibodi
direct
spike
glycoprotein
sar
coronaviru
prophylact
administr
antibodi
ferret
intratrach
challeng
high
dose
human
sar
coronaviru
complet
prevent
develop
lung
patholog
abolish
viral
shed
pharyng
secret
data
suggest
antibodi
prophylaxi
might
offer
clinic
protect
sar
block
airborn
transmiss
sar
coronaviru
evalu
potenti
antibodi
administr
prophylaxi
sar
outbreak
control
design
mathemat
model
model
distinct
made
sar
transmiss
infect
individu
hospit
consid
two
qualit
differ
strategi
antibodi
administr
first
preexposur
prophylaxi
target
suscept
person
come
contact
hospit
sar
case
eg
health
care
worker
close
friend
rel
second
postexposur
prophylaxi
target
expos
person
identifi
contact
trace
hospit
sar
case
base
model
deriv
express
effect
reproduct
number
sar
studi
condit
contain
explor
size
durat
outbreak
depend
efficaci
control
model
modif
discretetim
seir
model
modif
distinguish
infecti
individu
commun
hospit
possibl
put
quarantin
fig
suppos
death
recoveri
occur
person
admit
hospit
addit
suppos
infect
remov
constitut
small
fraction
total
popul
ie
taken
approxim
constant
simplifi
transmiss
dynam
essenti
linear
system
consequ
model
appli
stage
epidem
satur
incid
occur
due
high
preval
infect
andor
natur
immun
allow
timedepend
transit
transmiss
probabl
divid
everi
state
categori
denot
either
time
sinc
infect
time
sinc
onset
clinic
symptom
within
model
state
categori
independ
ident
distribut
bernoulli
trial
perform
everi
person
determin
whether
asymptomat
infect
person
becom
symptomat
thu
infect
probabl
f
whether
symptomat
infecti
person
admit
hospit
probabl
z
whether
hospit
patient
recov
die
complic
due
sar
probabl
g
paramet
f
depend
time
sinc
infect
wherea
paramet
z
g
depend
time
sinc
onset
clinic
symptom
infect
individu
also
depend
time
sinc
onset
clinic
symptom
time
infect
onset
clinic
symptom
durat
symptomat
period
reflect
specif
biolog
featur
virushost
interact
assum
distribut
affect
intervent
measur
assumpt
invari
distribut
seem
reason
therapeut
treatment
current
avail
sar
coronaviru
infect
follow
hospit
alter
overal
durat
symptomat
period
although
may
affect
infect
convers
condit
probabl
hospit
patient
recov
die
complic
due
sar
depend
cumul
probabl
person
articl
press
figur
schema
flow
individu
epidemiolog
compart
member
suscept
popul
compart
may
becom
infect
contact
infecti
person
infect
person
first
enter
asymptomat
phase
evid
presymptomat
transmiss
sar
assum
infect
begin
onset
clinic
symptom
henc
expos
popul
compart
e
compos
noninfecti
asymptomat
infect
individu
wherea
infecti
popul
compart
compos
symptomat
infect
individu
diagnos
sar
admit
hospit
superscript
h
death
sar
take
place
similar
timescal
recoveri
consid
composit
endpoint
person
either
die
recov
sar
compart
r
admit
hospit
follow
f
denot
cumul
probabl
infect
person
becom
symptomat
day
infect
g
denot
cumul
probabl
symptomat
person
recov
die
day
diseas
h
denot
probabl
symptomat
person
admit
hospit
day
diseas
b
denot
expect
number
secondari
infect
day
sinc
onset
clinic
symptom
product
infect
infect
individu
daili
number
close
contact
suscept
person
simul
purpos
assum
number
secondari
infect
follow
poisson
distribut
expect
b
hospit
result
transmiss
rate
reduct
number
secondari
infect
follow
poisson
distribut
expect
cb
let
h
denot
uncondit
probabl
person
admit
hospit
day
diseas
let
u
k
probabl
person
admit
hospit
day
diseas
discharg
day
k
assum
discharg
occur
person
admit
hospit
henc
g
ph
probabl
person
discharg
day
k
condit
admit
hospit
day
reproduct
number
infecti
diseas
defin
expect
number
secondari
case
gener
index
case
assum
transmiss
onset
clinic
symptom
occur
reproduct
number
formul
assum
f
g
determin
biolog
featur
viru
human
host
contrast
h
b
chang
adapt
behavior
although
extent
manipul
limit
infrastructur
behavior
constraint
given
function
distribut
onsettoadmiss
time
transmiss
rate
implement
public
health
measur
defin
basic
reproduct
number
r
averag
number
secondari
case
intervent
place
gener
control
measur
specif
aim
sar
coronaviru
infect
per
se
paper
focu
transmiss
rate
reduct
follow
hospit
lower
c
shorten
time
onset
diseas
hospit
admiss
alter
h
contact
rate
reduct
gener
popul
also
known
social
distanc
affect
expect
number
secondari
infect
day
prior
hospit
alter
b
administr
antibodi
consid
two
way
preexposur
prophylaxi
aim
prevent
infect
wherea
postexposur
prophylaxi
person
alreadi
infect
may
prevent
clinic
symptom
block
transmiss
end
defin
v
probabl
contact
person
transmit
infect
day
diseas
suppli
antibodi
develop
symptomat
diseas
let
w
k
denot
condit
probabl
person
transmit
infect
day
diseas
hospit
day
k
write
p
denot
traceabl
fraction
index
case
contact
adopt
fix
durat
r
day
contact
trace
transmiss
occur
within
hospit
w
express
reduc
els
w
k
evalu
condit
probabl
admit
hospit
day
henc
assum
contact
trace
postexposur
prophylaxi
perform
preexposur
prophylaxi
brought
hospitalbas
transmiss
end
expect
number
secondari
case
gener
index
case
reduc
defin
critic
immun
coverag
minim
fraction
p
contact
trace
within
r
day
immun
order
reduc
r
one
given
particular
r
model
paramet
baselin
valu
list
tabl
f
fit
gamma
distribut
mean
day
varianc
day
g
obtain
fit
weibul
distribut
time
symptom
onset
either
death
recoveri
use
percentag
surviv
minu
discharg
hospit
report
three
age
categori
obtain
mean
durat
day
taken
togeth
total
time
spent
compart
e
thu
averag
month
expect
number
secondari
infect
day
sinc
onset
clinic
symptom
assum
obey
function
form
form
suggest
observ
viral
load
pharyng
secret
peak
second
week
onset
clinic
symptom
declin
thereaft
addit
followup
studi
viral
shed
show
one
four
sar
patient
still
test
posit
month
symptom
onset
fit
b
percentag
test
posit
time
obtain
estim
paramet
product
infect
contact
rate
subsequ
rescal
obtain
given
basic
reproduct
number
r
averag
number
secondari
case
gener
index
case
issuanc
first
global
sar
alert
approxim
vari
substanti
time
geograph
locat
scale
b
presum
knowledg
h
c
h
assum
follow
gamma
distribut
varianc
set
equal
mean
obtain
paramet
literatur
pertain
sar
outbreak
hong
kong
scale
infecti
condit
mean
time
onset
diseas
diagnosi
day
averag
interv
hospit
admiss
week
prior
first
global
sar
alert
line
initi
estim
hospit
patient
transmit
infect
rate
symptomat
patient
commun
took
baselin
valu
c
outbreak
contain
whenev
expect
number
secondari
infect
gener
index
case
exce
one
condit
outbreak
control
formul
proport
secondari
infect
occur
prior
hospit
admiss
clearli
outbreak
contain
averag
index
case
transmit
infect
prior
hospit
admiss
thu
necessari
condit
outbreak
control
condit
met
communitybas
transmiss
enough
sustain
epidem
growth
condit
met
social
distanc
admiss
interv
reduct
use
baselin
paramet
valu
estim
yr
ie
mean
admiss
interv
day
approxim
two
everi
three
infect
occur
prior
hospit
admiss
social
distanc
alon
account
outbreak
control
contact
rate
would
declin
shorten
time
onset
diseas
hospit
admiss
therebi
decreas
opportun
communitybas
transmiss
effici
control
spread
sar
averag
admiss
interv
day
would
bring
yr
one
howev
c
number
secondari
infect
occur
within
hospit
enough
sustain
epidem
growth
admiss
interv
day
fig
hospit
transmiss
rate
need
less
communitybas
transmiss
order
achiev
without
reli
contact
rate
reduct
gener
popul
fig
sar
outbreak
character
consider
degre
heterogen
number
secondari
case
gener
index
case
epidem
curv
particularli
shape
occurr
cluster
except
high
transmiss
term
superspread
event
ss
extent
ss
affect
reproduct
number
infect
depend
rel
frequenc
magnitud
turn
determin
opportun
outbreak
control
therefor
investig
robust
control
admiss
interv
reduct
patient
isol
procedur
contain
sar
transmiss
rang
basic
reproduct
number
reduct
admiss
interv
insuffici
contain
sar
outbreak
r
c
patient
alreadi
admit
hospit
onset
clinic
symptom
correspond
zero
admiss
interv
hospit
outbreak
could
contain
r
c
r
c
r
c
fig
reduc
rel
rate
hospit
transmiss
thu
cumul
distribut
function
day
sinc
infect
z
mean
varianc
distribut
denot
respect
cumul
distribut
function
day
sinc
onset
clinic
symptom
z
shape
scale
distribut
denot
b
respect
implement
control
measur
yy
symbol
denot
time
day
sinc
onset
clinic
symptom
zz
fit
percentag
sar
patient
viral
shed
nasopharyng
aspir
subsequ
scale
r
yy
appli
model
preandor
postexposur
antibodi
prophylaxi
facilit
control
extend
rang
r
valu
especi
short
admiss
interv
preexposur
prophylaxi
target
suscept
person
come
contact
hospit
sar
patient
could
effect
reduc
hospit
transmiss
even
prophylaxi
would
limit
efficaci
rang
reproduct
number
outbreak
control
achiev
may
increas
significantli
patient
alreadi
admit
hospit
onset
clinic
symptom
rang
reproduct
number
contain
increas
factor
e
e
denot
fraction
target
popul
remain
suscept
spite
immun
exampl
antibodi
prophylaxi
would
render
three
four
person
nonsuscept
infect
ie
e
rang
reproduct
number
contain
would
increas
factor
four
fig
rang
reproduct
number
contain
admiss
interv
greater
zero
may
also
improv
significantli
target
preexposur
antibodi
prophylaxi
hospit
transmiss
could
block
complet
rang
r
valu
contain
increas
steepli
admiss
interv
reduct
fig
gener
measur
patient
isol
procedur
abl
reduc
hospit
transmiss
rate
c
outbreak
contain
r
admiss
interv
preexposur
antibodi
prophylaxi
target
come
contact
hospit
sar
patient
could
improv
condit
outbreak
control
r
e
r
e
critic
coverag
index
case
contact
must
suppli
postexposur
prophylaxi
achiev
increas
r
time
onset
diseas
hospit
admiss
larg
admiss
interv
outbreak
control
via
contact
trace
postexposur
prophylaxi
possibl
rel
low
transmiss
instanc
full
coverag
admiss
interv
would
suffic
keep
outbreak
bay
r
assum
transmiss
occur
hospit
tabl
dot
line
refer
condit
contain
b
dot
line
refer
baselin
valu
c
c
show
condit
contain
depend
basic
reproduct
number
dot
line
refer
baselin
valu
r
day
need
contact
trace
ie
c
r
fig
admiss
interv
full
coverag
could
suffici
contain
outbreak
character
r
postexposur
prophylaxi
gener
extend
rang
r
valu
contain
extent
control
facilit
depend
admiss
interv
extent
postexposur
prophylaxi
commun
enhanc
control
also
limit
time
requir
contact
trace
rang
reproduct
number
contain
declin
day
need
contact
trace
instanc
p
rang
reproduct
number
contain
admiss
interv
reduc
r
r
contact
trace
take
day
instead
one
fig
ongo
hospit
transmiss
effect
reduc
rang
control
achiev
especi
less
effect
contact
trace
fig
antibodi
prophylaxi
may
employ
achiev
achiev
alreadi
admiss
interv
reduct
patient
isol
procedur
antibodi
prophylaxi
might
also
employ
reduc
r
one
size
durat
outbreak
becom
increasingli
restrict
r
approach
zero
number
secondari
infect
follow
poisson
distribut
probabl
index
case
transmit
infect
exp
r
distribut
size
outbreak
x
gener
n
initi
case
form
distribut
appropri
defin
xxn
r
reduc
factor
j
probabl
transmiss
occur
n
initi
case
increas
factor
hand
probabl
outbreak
gener
n
initi
case
attain
final
size
decreas
factor
j
infer
expect
size
outbreak
diminish
r
approach
zero
benefit
antibodi
prophylaxi
reduc
r
one
verifi
stochast
simul
estim
outbreak
size
durat
base
thousand
model
run
seed
n
initi
case
r
simul
averag
time
onset
diseas
hospit
assum
declin
baselin
valu
day
first
coupl
sar
patient
identifi
hospit
transmiss
rate
set
communitybas
transmiss
measur
figur
critic
vaccin
coverag
contain
sar
transmiss
function
basic
reproduct
number
r
time
onset
diseas
hospit
admiss
b
assum
hospitalbas
transmiss
effect
block
ie
c
durat
contact
trace
postexposur
prophylaxi
set
r
day
r
day
b
c
durat
contact
trace
set
r
day
hospitalbas
transmiss
assum
continu
rate
communitybas
transmiss
ie
c
yield
r
henc
principl
enough
contain
outbreak
investig
addit
benefit
antibodi
prophylaxi
compar
baselin
model
model
preexposur
prophylaxi
given
person
come
contact
hospit
sar
patient
model
preand
postexposur
prophylaxi
given
fraction
person
contact
prior
hospit
admiss
latter
model
assum
contact
trace
within
day
index
case
hospit
admiss
outbreak
may
take
consider
time
subsid
public
health
measur
result
r
fig
total
size
outbreak
expect
n
initi
case
sd
take
averag
sd
day
last
patient
discharg
hospit
preexposur
prophylaxi
given
person
come
contact
hospit
sar
patient
result
r
fig
impact
reduct
reproduct
number
readili
appar
outbreak
size
durat
decreas
sd
case
sd
day
respect
ad
postexposur
prophylaxi
p
r
day
spectrum
control
measur
reduc
reproduct
number
r
fig
accordingli
expect
size
outbreak
decreas
sd
case
time
last
patient
discharg
hospit
decreas
sd
day
normal
variat
doubl
logarithm
scale
impli
highli
skew
distribut
outbreak
size
durat
inde
largescal
outbreak
repres
signific
proport
outcom
r
percentil
outbreak
size
durat
case
day
respect
fig
larg
outbreak
still
possibl
yet
becom
less
like
lower
reproduct
number
percentil
outbreak
size
case
r
fig
case
r
fig
reduct
may
achiev
faster
effect
contact
trace
admiss
interv
reduct
interv
hospit
admiss
day
contact
trace
r
percentil
outbreak
size
durat
case
day
respect
fig
paper
present
gener
model
initi
stage
sar
epidem
evalu
effect
differ
infect
control
measur
reproduct
number
r
defin
number
secondari
case
gener
index
case
specif
studi
target
administr
prophylact
antibodi
might
supplement
stringent
patient
isol
procedur
futur
sar
outbreak
mathemat
analysi
numer
simul
demonstr
addit
antibodi
prophylaxi
control
measur
gener
allow
contain
higher
r
valu
restrict
size
durat
outbreak
model
differ
publish
mathemat
sar
model
allow
nonconst
infect
cours
infect
strong
evid
viral
shed
slowli
increas
cours
infect
reach
peak
second
week
onset
clinic
symptom
suggest
assumpt
constant
infect
hold
analysi
model
use
nonconst
infect
reveal
control
sar
patient
isol
mainli
establish
due
rel
late
infect
peak
infect
henc
failur
captur
aspect
transmiss
dynam
sar
could
led
mislead
conclus
approach
differ
mathemat
sar
model
nonconst
infect
use
explicitli
allow
asymptomat
period
infect
transmiss
occur
henc
model
classifi
age
infect
model
infect
depend
time
sinc
onset
clinic
symptom
rather
time
sinc
infect
age
infect
model
would
allow
transmiss
occur
onset
clinic
symptom
supposit
isin
case
sarsnot
support
data
howev
conclus
would
alter
allow
possibl
presymptomat
transmiss
given
infect
earli
stage
infect
would
typic
low
final
model
parameter
empir
defin
wait
time
recent
demonstr
ignor
latent
period
infect
make
common
approxim
exponenti
distribut
wait
time
give
rise
overtli
optimist
predict
outcom
control
strategi
although
made
simplif
aspect
notabl
assumpt
constant
pool
suscept
individu
feel
model
accur
describ
initi
stage
epidem
point
patient
isol
principl
contain
outbreak
sar
provid
time
onset
admiss
short
contribut
measur
control
sar
epidem
eg
quarantin
expos
individu
widespread
use
facemask
debat
model
studi
aim
simul
potenti
respons
sar
japan
conclud
quarantin
expos
popul
would
one
effect
polici
procedur
even
suggest
despit
consider
cost
involv
quarantin
measur
canada
save
live
also
cost
impact
quarantin
remark
given
lack
presymptomat
transmiss
sar
within
model
framework
benefit
quarantin
expos
individu
interpret
term
admiss
interv
reduct
contact
rate
reduct
day
prior
hospit
result
line
find
person
protect
measur
gener
popul
use
facemask
offer
littl
protect
commun
also
demonstr
patient
isol
procedur
alon
prevent
sar
epidem
transmiss
rate
slightli
increas
compar
outbreak
unless
addit
measuressuch
contact
trace
put
place
find
reminisc
model
result
obtain
smallpox
control
new
variant
sar
coronaviru
initi
anoth
epidem
question
extent
resembl
etiolog
agent
first
outbreak
sar
epidem
character
high
degre
heterogen
number
secondari
case
gener
index
case
whether
heterogen
repres
variabl
viral
biolog
host
behavior
unclear
avail
data
suggest
sar
highli
contagi
etiolog
agent
sar
continu
circul
natur
host
speci
may
evolv
transmiss
strain
maxim
opportun
contain
potenti
transmiss
sar
coronaviru
variant
minim
size
durat
outbreak
exist
control
strategi
supplement
specif
antivir
strategi
passiv
immun
would
seem
appropri
conting
situat
provid
person
instant
albeit
shortliv
protect
infect
could
also
use
postexposur
prophylaxi
prevent
diseas
progress
rabi
passiv
immun
commonli
use
combin
vaccin
prevent
rabiesexpos
individu
becom
symptomat
communitywid
contain
infecti
diseas
outbreak
mean
antibodi
prophylaxi
describ
number
case
late
outbreak
hepat
religi
commun
provid
opportun
assess
impact
immun
globulin
cours
outbreak
incid
hepat
among
immun
globulin
recipi
stop
week
campaign
mass
administr
passiv
immun
use
polyclon
sera
also
report
prevent
infect
respiratori
virus
previous
character
monoclon
antibodi
direct
spike
glycoprotein
sar
coronaviru
highli
effect
test
ferret
result
preclin
develop
demonstr
combin
two
monoclon
antibodi
sar
act
synergist
hint
prospect
antibodi
cocktail
feasibl
effici
prophylaxi
monoclon
antibodi
cocktail
target
two
distinct
epitop
receptorbind
domain
spike
glycoprotein
one
recogn
residu
critic
adapt
human
transmiss
evolut
toward
human
transmiss
novel
sarslik
coronavirus
would
like
requir
adapt
thu
preserv
neutral
potenti
antibodi
cocktail
case
new
sar
outbreak
occur
extent
antibodi
prophylaxi
may
enhanc
sar
outbreak
control
measur
hing
transmiss
diseas
effect
gener
infect
control
measur
introduc
comprehens
conting
plan
control
futur
sar
outbreak
aim
maxim
rang
r
valu
contain
minim
size
durat
outbreak
analysi
demonstr
antibodi
prophylaxi
would
effect
addendum
array
exist
public
health
measur
control
sar
